Motley Fool Australia

Medical Developments International Ltd (ASX: MVP) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $398.37 million
P/E Ratio 1,000.00
Dividend Yield 0.36%
Shares Outstanding 71.26 million
Earnings per share -0.015
Dividend per share 0.04
Year To Date Return -16.92%
Earnings Yield 0.10%
Franking 100%

Medical Developments International Ltd (ASX: MVP) Latest News

Financial Technology

Insiders have been buying Sydney Airport (ASX:SYD) and this ASX share

More »

jump in asx share price represented by man jumping in the air in celebration

The Medical Developments International (ASX:MVP) share price is jumping 7% today

More »

jump in asx share price represented by man jumping in the air in celebration

Why the Medical Developments International (ASX:MVP) share price jumped 5% higher

More »

falling asx share price represented by toy rocket crashed into ground

Why Emerge Gaming, Flight Centre, Medical Dev International, & Tyro shares are dropping lower

More »

asx share price falling represented by graph of paper plane trending down

Why the Medical Developments International (ASX:MVP) share price is sinking lower

More »

asx share price falling represented by graph of paper plane trending down

Why BetMakers, Medical Development International, Qantas, & Zip are dropping lower

More »

ASX share price on watch represented by surprised man with binoculars

Medical Developments International (ASX:MVP) share price on watch after trading update

More »

Doctor holding small world globe in one hand and a Covid vaccine needle in the other

2 ASX healthcare shares that have risen since Pfizer’s vaccine news

More »

Dividend Payment History

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
05 Mar 2020 $0.0200 100.00% Interim 17 Apr 2020
03 Sep 2019 $0.0200 100.00% Final 04 Oct 2019
07 Mar 2019 $0.0200 100.00% Interim 17 Apr 2019
30 Aug 2018 $0.0200 100.00% Final 05 Oct 2018
02 Mar 2018 $0.0200 100.00% Interim 13 Apr 2018
31 Aug 2017 $0.0200 100.00% Final 06 Oct 2017
03 Mar 2017 $0.0200 100.00% Interim 10 Apr 2017
01 Sep 2016 $0.0200 100.00% Final 07 Oct 2016
02 Mar 2016 $0.0200 100.00% Interim 08 Apr 2016
02 Sep 2013 $0.0200 100.00% Final 11 Oct 2013
27 Feb 2013 $0.0300 100.00% Interim 11 Apr 2013
28 Feb 2012 $0.0300 100.00% Interim 11 Apr 2012
31 Aug 2011 $0.0300 100.00% Final 10 Oct 2011
Show more

Yearly Dividend Payment Chart

Data provided by Morningstar.

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About Medical Developments International Ltd (ASX: MVP)

Medical Developments International Ltd is a specialized healthcare company. It manufactures and distributes the pharmaceutical drug and medical and veterinary equipment. The company provides a range of products in the areas of pain management, asthma, and resuscitation, plus veterinary equipment. It is organized into three business units: Pharmaceuticals, Medical Devices, and Veterinary products. Majority of its revenue comes from Pharmaceuticals Unit which engages in the sale of Penthrox primarily within Australia, New Zealand, Europe the UK and some sales in Canada, the Middle East, Asia and South Africa.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
12 Apr 2021 $5.59 $0.04 0.72% 53,697 $5.57 $5.63 $5.53
09 Apr 2021 $5.55 $0.05 0.91% 58,111 $5.50 $5.57 $5.41
08 Apr 2021 $5.50 $0.20 3.77% 58,595 $5.40 $5.50 $5.34
07 Apr 2021 $5.30 $-0.12 -2.21% 56,911 $5.42 $5.50 $5.30
06 Apr 2021 $5.42 $0.14 2.65% 26,965 $5.38 $5.42 $5.28
01 Apr 2021 $5.28 $0.07 1.34% 50,497 $5.21 $5.37 $5.20
31 Mar 2021 $5.21 $0.00 0.00% 43,415 $5.25 $5.38 $5.21
30 Mar 2021 $5.21 $-0.29 -5.27% 45,781 $5.49 $5.49 $5.20
29 Mar 2021 $5.50 $0.25 4.76% 64,466 $5.27 $5.50 $5.25
26 Mar 2021 $5.25 $0.05 0.96% 61,499 $5.29 $5.44 $5.21
25 Mar 2021 $5.20 $-0.23 -4.24% 106,168 $5.43 $5.43 $5.16
24 Mar 2021 $5.43 $-0.28 -4.90% 84,342 $5.51 $5.64 $5.36
23 Mar 2021 $5.71 $0.17 3.07% 69,334 $5.60 $5.71 $5.37
22 Mar 2021 $5.54 $0.17 3.17% 146,178 $5.35 $5.54 $5.34
19 Mar 2021 $5.37 $-0.20 -3.59% 147,001 $5.53 $5.56 $5.28
18 Mar 2021 $5.57 $0.07 1.27% 46,860 $5.61 $5.65 $5.50
17 Mar 2021 $5.50 $-0.11 -1.96% 50,709 $5.61 $5.65 $5.49
16 Mar 2021 $5.61 $0.09 1.63% 72,434 $5.56 $5.67 $5.50
15 Mar 2021 $5.52 $-0.12 -2.13% 86,191 $5.65 $5.79 $5.52
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
25 Mar 2021 Leon Hoare Buy 5 $29,260
09 Mar 2021 Gordon Naylor Buy 37 $200,801
08 Mar 2021 Gordon Naylor Buy 62 $335,169
08 Mar 2021 Maria (Mary) Sontrop Buy 18 $100,054
27 Jan 2021 Leon Hoare Issued 4 $29,997
27 Jan 2021 David Williams Issued 18 $119,990
27 Jan 2021 Philip (Phil) Powell Issued 4 $29,997
27 Jan 2021 Robert (Max) Johnston Issued 4 $29,997
27 Jan 2021 Gordon Naylor Issued 4 $29,997
14 Dec 2020 David Williams Sell 154 $1,001,000
14 Dec 2020 Gordon Naylor Buy 154 $1,001,000
08 Sep 2020 Leon Hoare Buy 7 $37,935
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Mr David Williams Non-Executive Director,Non-Executive Chairman Feb 2010
Mr Philip (Phil) John Powell Non-Executive Director Dec 2014
Mr Robert (Max) Maxwell Johnston Non-Executive Director,Acting Chief Executive Officer Nov 2012
Mr Leon Hoare Non-Executive Director
Ms Maria (Mary) Elisabeth Sontrop Non-Executive Director Mar 2021
Ms Christine Emmanuel Non-Executive Director May 2020
Mr Gordon Naylor Non-Executive Director,Non-Executive Chairman Oct 2020
Mr Mark Edwards Group Financial Controller,Company Secretary Jun 2014
Mr Brent MacGregor Chief Executive Officer Nov 2020
Brent MacGregor Chief Executive Officer
Mark Edwards Group Financial Controller,Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Mr David John Williams 9,650,782 14.71%
HSBC Custody Nominees 6,685,759 10.19%
J P Morgan Nominees Australia 4,249,171 6.48%
Citicorp Nominees Pty Limited 3,319,510 5.06%
Netwealth Investments Limited 1,620,522 2.47%
Dr Russell Kay Hancock 1,614,214 2.46%
Sandhurst Trustees 1,053,413 1.61%
Ubs Nominees 874,242 1.33%
National Nominees Limited 712,776 1.09%
Mr Alistair David Strong 630,000 0.96%
Warbont Nominees Pty Ltd 532,983 0.81%
Mrs Virgina Catherine Hancock 518,487 0.79%
Cs Fourth Nominees 507,331 0.77%
Jj Opperman Superannuation Pty Limited 300,000 0.46%
Pnsf Pty Ltd 264,565 0.40%
Mr Michael Clifford Hickling & Mrs Giovanna Hickling 255,936 0.39%
Imaj Pty Ltd 253,750 0.39%
Capricorn Investment Partners (Nominees) Pty Ltd 250,000 0.38%
BNP Paribas Nominees Pty Ltd 215,940 0.33%
Hollywind Pty Ltd 200,000 0.30%
Show more